Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV002261661 | SCV002541758 | uncertain significance | not provided | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496193 | SCV002777887 | uncertain significance | Glycogen storage disease due to phosphoglycerate kinase 1 deficiency | 2022-04-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002261661 | SCV004616587 | benign | not provided | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004548251 | SCV004795473 | likely benign | PGK1-related disorder | 2021-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |